1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kim, K.-S. Clark-Lewis, I. Sykes, B.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 269 32909 32915 7806518 Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy. 1994 10.2210/pdb1msg/pdb pdb_00001msg 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 7763.112 HUMAN MELANOMA GROWTH STIMULATORY ACTIVITY 2 man polymer no no ASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKNGRKACLNPASPIVKKIIEKMLNSDKS ASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKNGRKACLNPASPIVKKIIEKMLNSDKS A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1995-03-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1995-01-25 REL 1 BRUNGER refinement X-PLOR ALA 1 n 1 ALA 1 A SER 2 n 2 SER 2 A VAL 3 n 3 VAL 3 A ALA 4 n 4 ALA 4 A THR 5 n 5 THR 5 A GLU 6 n 6 GLU 6 A LEU 7 n 7 LEU 7 A ARG 8 n 8 ARG 8 A CYS 9 n 9 CYS 9 A GLN 10 n 10 GLN 10 A CYS 11 n 11 CYS 11 A LEU 12 n 12 LEU 12 A GLN 13 n 13 GLN 13 A THR 14 n 14 THR 14 A LEU 15 n 15 LEU 15 A GLN 16 n 16 GLN 16 A GLY 17 n 17 GLY 17 A ILE 18 n 18 ILE 18 A HIS 19 n 19 HIS 19 A PRO 20 n 20 PRO 20 A LYS 21 n 21 LYS 21 A ASN 22 n 22 ASN 22 A ILE 23 n 23 ILE 23 A GLN 24 n 24 GLN 24 A SER 25 n 25 SER 25 A VAL 26 n 26 VAL 26 A ASN 27 n 27 ASN 27 A VAL 28 n 28 VAL 28 A LYS 29 n 29 LYS 29 A SER 30 n 30 SER 30 A PRO 31 n 31 PRO 31 A GLY 32 n 32 GLY 32 A PRO 33 n 33 PRO 33 A HIS 34 n 34 HIS 34 A CYS 35 n 35 CYS 35 A ALA 36 n 36 ALA 36 A GLN 37 n 37 GLN 37 A THR 38 n 38 THR 38 A GLU 39 n 39 GLU 39 A VAL 40 n 40 VAL 40 A ILE 41 n 41 ILE 41 A ALA 42 n 42 ALA 42 A THR 43 n 43 THR 43 A LEU 44 n 44 LEU 44 A LYS 45 n 45 LYS 45 A ASN 46 n 46 ASN 46 A GLY 47 n 47 GLY 47 A ARG 48 n 48 ARG 48 A LYS 49 n 49 LYS 49 A ALA 50 n 50 ALA 50 A CYS 51 n 51 CYS 51 A LEU 52 n 52 LEU 52 A ASN 53 n 53 ASN 53 A PRO 54 n 54 PRO 54 A ALA 55 n 55 ALA 55 A SER 56 n 56 SER 56 A PRO 57 n 57 PRO 57 A ILE 58 n 58 ILE 58 A VAL 59 n 59 VAL 59 A LYS 60 n 60 LYS 60 A LYS 61 n 61 LYS 61 A ILE 62 n 62 ILE 62 A ILE 63 n 63 ILE 63 A GLU 64 n 64 GLU 64 A LYS 65 n 65 LYS 65 A MET 66 n 66 MET 66 A LEU 67 n 67 LEU 67 A ASN 68 n 68 ASN 68 A SER 69 n 69 SER 69 A ASP 70 n 70 ASP 70 A LYS 71 n 71 LYS 71 A SER 72 n 72 SER 72 A ALA 1 n 1 ALA 1 B SER 2 n 2 SER 2 B VAL 3 n 3 VAL 3 B ALA 4 n 4 ALA 4 B THR 5 n 5 THR 5 B GLU 6 n 6 GLU 6 B LEU 7 n 7 LEU 7 B ARG 8 n 8 ARG 8 B CYS 9 n 9 CYS 9 B GLN 10 n 10 GLN 10 B CYS 11 n 11 CYS 11 B LEU 12 n 12 LEU 12 B GLN 13 n 13 GLN 13 B THR 14 n 14 THR 14 B LEU 15 n 15 LEU 15 B GLN 16 n 16 GLN 16 B GLY 17 n 17 GLY 17 B ILE 18 n 18 ILE 18 B HIS 19 n 19 HIS 19 B PRO 20 n 20 PRO 20 B LYS 21 n 21 LYS 21 B ASN 22 n 22 ASN 22 B ILE 23 n 23 ILE 23 B GLN 24 n 24 GLN 24 B SER 25 n 25 SER 25 B VAL 26 n 26 VAL 26 B ASN 27 n 27 ASN 27 B VAL 28 n 28 VAL 28 B LYS 29 n 29 LYS 29 B SER 30 n 30 SER 30 B PRO 31 n 31 PRO 31 B GLY 32 n 32 GLY 32 B PRO 33 n 33 PRO 33 B HIS 34 n 34 HIS 34 B CYS 35 n 35 CYS 35 B ALA 36 n 36 ALA 36 B GLN 37 n 37 GLN 37 B THR 38 n 38 THR 38 B GLU 39 n 39 GLU 39 B VAL 40 n 40 VAL 40 B ILE 41 n 41 ILE 41 B ALA 42 n 42 ALA 42 B THR 43 n 43 THR 43 B LEU 44 n 44 LEU 44 B LYS 45 n 45 LYS 45 B ASN 46 n 46 ASN 46 B GLY 47 n 47 GLY 47 B ARG 48 n 48 ARG 48 B LYS 49 n 49 LYS 49 B ALA 50 n 50 ALA 50 B CYS 51 n 51 CYS 51 B LEU 52 n 52 LEU 52 B ASN 53 n 53 ASN 53 B PRO 54 n 54 PRO 54 B ALA 55 n 55 ALA 55 B SER 56 n 56 SER 56 B PRO 57 n 57 PRO 57 B ILE 58 n 58 ILE 58 B VAL 59 n 59 VAL 59 B LYS 60 n 60 LYS 60 B LYS 61 n 61 LYS 61 B ILE 62 n 62 ILE 62 B ILE 63 n 63 ILE 63 B GLU 64 n 64 GLU 64 B LYS 65 n 65 LYS 65 B MET 66 n 66 MET 66 B LEU 67 n 67 LEU 67 B ASN 68 n 68 ASN 68 B SER 69 n 69 SER 69 B ASP 70 n 70 ASP 70 B LYS 71 n 71 LYS 71 B SER 72 n 72 SER 72 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 B O ALA 50 B O ALA 50 B N ALA 42 B N ALA 42 B O GLU 39 B O GLU 39 B N LYS 29 B N LYS 29 B O VAL 26 B O VAL 26 A N VAL 28 A N VAL 28 A O SER 25 A O SER 25 A N THR 43 A N THR 43 A O ALA 42 A O ALA 42 A N ALA 50 A N ALA 50 1 A A O H LYS LYS 61 65 1.57 1 B B O H LYS LYS 61 65 1.57 1 A ARG 8 0.317 SIDE CHAIN 1 A ARG 48 0.316 SIDE CHAIN 1 B ARG 8 0.317 SIDE CHAIN 1 B ARG 48 0.316 SIDE CHAIN 1 A THR 5 -95.96 56.17 1 A GLU 6 -165.11 92.95 1 A CYS 11 -33.54 134.65 1 A GLN 13 -170.27 42.61 1 A THR 14 30.08 96.43 1 A PRO 20 -75.75 -122.13 1 A LYS 21 74.21 -50.34 1 A ILE 23 -45.68 107.38 1 A PRO 33 -73.07 -158.84 1 A ALA 36 33.05 44.03 1 A THR 38 -64.93 -163.55 1 A VAL 40 -154.59 71.36 1 A ARG 48 -109.17 -168.35 1 A ASN 68 -71.50 -97.10 1 A SER 69 56.86 71.74 1 B THR 5 -96.66 56.48 1 B GLU 6 -165.71 92.16 1 B CYS 11 -25.65 130.63 1 B GLN 13 -171.63 42.40 1 B THR 14 29.78 96.69 1 B PRO 20 -75.97 -122.04 1 B LYS 21 74.15 -50.42 1 B ILE 23 -45.77 107.46 1 B PRO 33 -72.92 -159.64 1 B ALA 36 36.95 40.95 1 B THR 38 -65.35 -163.40 1 B VAL 40 -154.51 71.84 1 B ARG 48 -109.07 -168.35 1 B ASN 68 -71.45 -97.29 1 B SER 69 57.21 72.95 model building X-PLOR refinement X-PLOR phasing X-PLOR SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY 1 N N 1 N N A PRO 57 A PRO 57 HELX_P A LEU 67 A LEU 67 1 1 11 B PRO 57 B PRO 57 HELX_P B LEU 67 B LEU 67 1 2 11 disulf 2.023 A CYS 9 A SG CYS 9 1_555 A CYS 35 A SG CYS 35 1_555 disulf 2.023 A CYS 11 A SG CYS 11 1_555 A CYS 51 A SG CYS 51 1_555 CYTOKINE (CHEMOTACTIC) CYTOKINE (CHEMOTACTIC) GROA_HUMAN UNP 1 1 P09341 MARAALSAAPSNPRLLRVALLLLLLVAAGRRAAGASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKN GRKACLNPASPIVKKIIEKMLNSDKSN 35 106 1MSG 1 72 P09341 A 1 1 72 35 106 1MSG 1 72 P09341 B 1 1 72 6 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel B LYS 49 B LYS 49 B CYS 51 B CYS 51 B GLU 39 B GLU 39 B THR 43 B THR 43 B SER 25 B SER 25 B LYS 29 B LYS 29 A SER 25 A SER 25 A LYS 29 A LYS 29 A GLU 39 A GLU 39 A THR 43 A THR 43 A LYS 49 A LYS 49 A CYS 51 A CYS 51 1 P 1